Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

49 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Potassium Ascorbate with Ribose: Promising Therapeutic Approach for Melanoma Treatment.
Cavicchio C, Benedusi M, Pambianchi E, Pecorelli A, Cervellati F, Savelli V, Calamandrei D, Maellaro E, Rispoli G, Maioli E, Valacchi G. Cavicchio C, et al. Among authors: savelli v. Oxid Med Cell Longev. 2017;2017:4256519. doi: 10.1155/2017/4256519. Epub 2017 Sep 24. Oxid Med Cell Longev. 2017. PMID: 29290903 Free PMC article.
Impaired enzymatic defensive activity, mitochondrial dysfunction and proteasome activation are involved in RTT cell oxidative damage.
Cervellati C, Sticozzi C, Romani A, Belmonte G, De Rasmo D, Signorile A, Cervellati F, Milanese C, Mastroberardino PG, Pecorelli A, Savelli V, Forman HJ, Hayek J, Valacchi G. Cervellati C, et al. Among authors: savelli v. Biochim Biophys Acta. 2015 Oct;1852(10 Pt A):2066-74. doi: 10.1016/j.bbadis.2015.07.014. Epub 2015 Jul 17. Biochim Biophys Acta. 2015. PMID: 26189585 Free article.
Feasibility of modified docetaxel, oxaliplatin, capecitabine followed by capecitabine as maintenance chemotherapy as first-line therapy for patients with metastatic gastric or gastroesophageal cancer.
Petrioli R, Francini E, Cherri S, Marrelli D, Rovello F, Fiaschi AI, Miano ST, Savelli V, Calomino N, Farsi M, Vernillo R, Francini G. Petrioli R, et al. Among authors: savelli v. Anticancer Drugs. 2020 Mar;31(3):292-297. doi: 10.1097/CAD.0000000000000877. Anticancer Drugs. 2020. PMID: 31850915
Pathological response and outcome after neoadjuvant chemotherapy with DOC (docetaxel, oxaliplatin, capecitabine) or EOF (epirubicin, oxaliplatin, 5-fluorouracil) for clinical T3-T4 non-metastatic gastric cancer.
Petrioli R, Marrelli D, Roviello F, D'Ignazio A, Torre P, Chirra M, Savelli V, Ambrosio MR, Francini G, Calomino N, Farsi M, Vernillo R, Francini E. Petrioli R, et al. Among authors: savelli v. Surg Oncol. 2020 Mar;32:2-7. doi: 10.1016/j.suronc.2019.10.002. Epub 2019 Oct 2. Surg Oncol. 2020. PMID: 31670056
Chemo-hormone therapy of non-well-differentiated endocrine tumours from different anatomic sites with cisplatinum, etoposide and slow release lanreotide formulation.
Correale P, Sciandivasci A, Intrivici C, Pascucci A, Del Vecchio MT, Marsili S, Savelli V, Voltolini L, Di Bisceglie M, Guarnieri A, Gotti G, Francini G. Correale P, et al. Among authors: savelli v. Br J Cancer. 2007 May 7;96(9):1343-7. doi: 10.1038/sj.bjc.6603734. Epub 2007 Apr 17. Br J Cancer. 2007. PMID: 17437022 Free PMC article. Clinical Trial.
49 results